Literature DB >> 24247367

Rheumatoid arthritis: Testing the inflammation-insulin resistance link in clinical trials.

Naveed Sattar1, George D Kitas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24247367     DOI： 10.1038/nrrheum.2013.178

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  9 in total

Review 1.  Role of endoplasmic reticulum stress and c-Jun NH2-terminal kinase pathways in inflammation and origin of obesity and diabetes.

Authors:  Gökhan S Hotamisligil
Journal:  Diabetes       Date:  2005-12       Impact factor: 9.461

2.  Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS).

Authors:  Paul M Ridker; Tom Thuren; Andrew Zalewski; Peter Libby
Journal:  Am Heart J       Date:  2011-09-14       Impact factor: 4.749

Review 3.  Thiazolidinediones and PPARγ agonists: time for a reassessment.

Authors:  Bertrand Cariou; Bernard Charbonnel; Bart Staels
Journal:  Trends Endocrinol Metab       Date:  2012-04-17       Impact factor: 12.015

4.  C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study.

Authors:  Dilys J Freeman; John Norrie; Muriel J Caslake; Allan Gaw; Ian Ford; Gordon D O Lowe; Denis St J O'Reilly; Chris J Packard; Naveed Sattar
Journal:  Diabetes       Date:  2002-05       Impact factor: 9.461

5.  Obesity-induced inflammatory changes in adipose tissue.

Authors:  Kathryn E Wellen; Gokhan S Hotamisligil
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

6.  Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial.

Authors:  Eugene S Chung; Milton Packer; Kim Hung Lo; Adedigbo A Fasanmade; James T Willerson
Journal:  Circulation       Date:  2003-06-09       Impact factor: 29.690

7.  Anti-tumour necrosis factor alpha therapy improves insulin sensitivity in normal-weight but not in obese patients with rheumatoid arthritis.

Authors:  Antonios Stavropoulos-Kalinoglou; Giorgos S Metsios; Vasileios F Panoulas; Peter Nightingale; Yiannis Koutedakis; George D Kitas
Journal:  Arthritis Res Ther       Date:  2012-07-05       Impact factor: 5.156

8.  Peroxisome proliferator-activated receptor γ agonist effect on rheumatoid arthritis: a randomized controlled trial.

Authors:  Michelle J Ormseth; Annette M Oeser; Andrew Cunningham; Aihua Bian; Ayumi Shintani; Joseph Solus; S Tanner; C Michael Stein
Journal:  Arthritis Res Ther       Date:  2013       Impact factor: 5.156

9.  Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data.

Authors:  Frances Wensley; Pei Gao; Stephen Burgess; Stephen Kaptoge; Emanuele Di Angelantonio; Tina Shah; James C Engert; Robert Clarke; George Davey-Smith; Børge G Nordestgaard; Danish Saleheen; Nilesh J Samani; Manjinder Sandhu; Sonia Anand; Mark B Pepys; Liam Smeeth; John Whittaker; Juan Pablo Casas; Simon G Thompson; Aroon D Hingorani; John Danesh
Journal:  BMJ       Date:  2011-02-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.